Patents by Inventor Gil M. Lewitus

Gil M. Lewitus has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • GPR54 agonists or antagonists for treatment of diseases presenting behavioral abnormalities
    Patent number: 8716228
    Abstract: Use of a GPR54 agonist or antagonist for the treatment of a disease or disorder presenting behavioral abnormalities associated with impairment of sensory gating function, and/or for treatment of depression, and/or for improving cognitive function is disclosed. In particular, the invention relates to the use of kisspeptin or a peptide thereof for the treatment of schizophrenia.
    Type: Grant
    Filed: May 27, 2010
    Date of Patent: May 6, 2014
    Assignee: YEDA Research and Development Co. Ltd.
    Inventors: Michal Eisenbach-Schwartz, Gil M Lewitus, Michal Cardon-Yaakov, Noga Ron-Harel
  • GPR54 AGONISTS OR ANTAGONISTS FOR TREATMENT OF DISEASES PRESENTING BEHAVIORAL ABNORMALITIES
    Publication number: 20120135935
    Abstract: Use of a GPR54 agonist or antagonist for the treatment of a disease or disorder presenting behavioral abnormalities associated with impairment of sensory gating function, and/or for treatment of depression, and/or for improving cognitive function is disclosed.
    Type: Application
    Filed: May 27, 2010
    Publication date: May 31, 2012
    Inventors: Michal Eisenbach-Schwartz, Gil M. Lewitus, Michal Cardon-Yaakov, Noga Ron-Harel
  • AGENTS AND METHODS FOR TREATMENT OF ANXIETY DISORDERS
    Publication number: 20110033488
    Abstract: Peptides derived from CNS-specific antigens, altered peptide ligands (APL) analogues of said peptides, T cells activated by such peptides, poly-YE, and any combination of said agents are useful for prevention, treatment and/or alleviation of anxiety disorders, particularly post-traumatic stress disorder, and for restoring BDNF levels in the brain of an individual after reduction of BDNF expression induced by stress.
    Type: Application
    Filed: April 16, 2009
    Publication date: February 10, 2011
    Applicant: Yeda Research and Development Co. Ltd.
    Inventors: Michal Eisenbach-Schwartz, Gil M. Lewitus